FluoGuide A/S is a clinical stage biotechnology company, which engages in the development of drugs used for the improvement of surgical outcomes by making cancer fluorescent. Its technology includes uPAR, fluorescent guidance to surgical oncologists, and photothermal treatment. The company was founded by Andreas Kjaer on January 30, 2018 and is headquartered in Copenhagen, Denmark.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company